|
|
|
Volumn 16, Issue 6 Suppl 6, 2002, Pages 45-51
|
|
Docetaxel for previously treated non-small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MORTALITY;
PHASE 3 CLINICAL TRIAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE III;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
TAXOIDS;
|
|
EID: 0036617868
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (19)
|
|
References (12)
|
